Indications

PegAltevir® is used as a component of combined therapy for genotype I chronic viral hepatitis C.

Strength and Dosage Form

Lyophilizate for solution for subcutaneous injection, supplied with diluent. 50 mcg, 80 mcg, 100 mcg, 120 mcg or 150 mcg per vial; diluent (water for injection) 0.7 mL per ampoule.

Composition

Peginterferon alfa-2b, sodium hydrophosphate, sodium dihydrophosphate dehydrate, saccharose, polysorbate 80.

Pharmacological group

ATC: L03AB10 (Cytokine).